Mirum Pharmaceuticals, Inc. shows strong growth with a 43% revenue jump and promising pipeline assets. Click here for my ...
It can be frustrating to diagnose HPS because there are no specific tests for it. To diagnose, doctors tend to look at the ...
The FDA has approved Novartis’ Fabhalta (iptacopan) as the first and only treatment for C3 glomerulopathy (C3G). Previously, patients with C3G were forced to rely on supportive care and broad ...
MONDAY, March 24, 2025 (HealthDay News) -- A rare red meat allergy, usually linked to a bite from the lone star tick, may ...
Our findings suggest deeper issues are contributing to the increase in the disease, particularly in Black women. Barriers to health care are critical. These include insurance gaps, transportation ...
Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that ...
A new international study has offered hope that Alzheimer’s disease may one day be preventable—at least in people genetically ...
New medicines are being developed for individual treatments based on someone’s DNA. Those would be allowed under a proposed ...
Recent viral mutations have shown avian influenza’s adaptability to mammalian hosts, prompting infectious disease, animal ...
Dilgen, a 22-year-old Tottenville resident, has been battling epidermolysis bullosa (EB), a rare, life-threatening genetic ...
In one tiny town, more than a dozen people were diagnosed with the rare neurodegenerative disease ALS. Why? I n March 2009, ...
He took the stage and was great last week at the Grand Ole Opry’s 100th anniversary show, and now he is down to just two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback